Calithera Biosciences, Inc. is a clinical stage precision oncology biopharmaceutical company, which engages in developing targeted therapies to redefine treatment for biomarker-specific patient populations. The company is headquartered in South San Francisco, California and currently employs 8 full-time employees. The company went IPO on 2014-10-02. The firm is winding up its operations. The firm is seeking to sell all of its clinical assets and programs. The firm has not generated any revenue.
Calithera Biosciences Inc'in kazanç kalite puanı B+/50.857918'dir. Puan, karlılık, büyüme, nakit üretimi ve sermaye tahsisi ile kaldıraç olmak üzere dört boyuta dayanır.
Calithera Biosciences Inc kazançlarını ne zaman rapor eder?
Calithera Biosciences Inc'in bir sonraki kazanç raporu 2024-06-27'te bekleniyor